Our Pricing

Cheapest Wegovy UK: Prescription Weight Loss From £69.00

Published on: June 03, 2026

Looking for the cheapest Wegovy UK online pharmacy with transparent pricing? At Cured Pharmacy, you'll find genuine UK-licensed Wegovy (semaglutide) injections from £79.00, with free clinical consultations completed in under 3 minutes and 100% discreet delivery to your door. Our UK-registered prescribers assess every patient individually, ensuring safe, effective weight management support.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics a natural hormone called glucagon-like peptide-1, which regulates appetite centres in the brain and slows gastric emptying, helping you feel fuller for longer after meals.

In the landmark STEP 1 trial, participants using Wegovy alongside lifestyle interventions achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. These results represent one of the most significant advances in pharmacological weight management in the past decade, offering genuine support for patients who have struggled with diet and exercise alone.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a gradual dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Treatment begins at 0.25mg once weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg, reaching the maintenance dose of 2.4mg by week 17 [2].

This titration schedule allows your body to adapt to the medication progressively. Most patients tolerate the increases well, though mild nausea is common during the first few weeks and typically subsides as treatment continues. Your UK prescriber will monitor your progress at each dose level, ensuring the treatment remains appropriate and effective for your individual circumstances.

Managing Side Effects During Treatment

The most frequently reported side effects in clinical trials were gastrointestinal: nausea (44%), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These effects are generally mild to moderate, occur primarily during dose escalation, and diminish over time. Eating smaller, more frequent meals and avoiding high-fat foods can help reduce discomfort. If side effects persist or become troublesome, your prescriber may adjust your dosing schedule accordingly.

Cheapest Wegovy UK: Understanding Transparent Pricing

At Cured Pharmacy, Wegovy starts from £79.00 per pen, with pricing displayed upfront before your consultation begins. Unlike some services that reveal costs only after lengthy assessments, we believe in complete transparency so you can make informed decisions about your weight loss journey from the outset.

Our pricing includes your medication, free clinical consultation with a UK-registered prescriber, ongoing support from our pharmacy team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), and discreet home delivery. There are no hidden fees, subscription traps, or unexpected charges. What you see is what you pay, making us consistently the cheapest Wegovy UK option without compromising on clinical quality or patient safety.

Price Match Guarantee

We guarantee the lowest Wegovy prices in the UK. If you find genuine UK-licensed Wegovy available from another GPhC-registered pharmacy at a lower price, we'll match it. Our commitment to affordable access means you never have to choose between cost and quality when it comes to your health.

Who Can Use Wegovy: Eligibility Criteria

Wegovy is licensed in the UK for adults with an initial BMI of 30 kg/m² or greater (obesity), or 27 kg/m² or greater (overweight) in the presence of at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. NICE guidance recommends considering GLP-1 receptor agonists for weight management when lifestyle interventions alone have not achieved adequate results.

During your free online consultation, our UK prescriber will review your medical history, current medications, and weight loss goals to determine whether Wegovy is clinically appropriate for you. Certain conditions may make semaglutide unsuitable, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Pregnancy and breastfeeding are also contraindications, as safety data in these populations remains limited [2].

Wegovy vs Other Weight Loss Treatments

Several prescription weight loss treatments are now available through UK pharmacies, each with distinct mechanisms, dosing schedules, and efficacy profiles. Wegovy contains semaglutide, a GLP-1 receptor agonist administered once weekly by subcutaneous injection. Alternative injectable options include liraglutide (daily dosing) and tirzepatide (once weekly, dual GIP/GLP-1 mechanism).

Head-to-head trials have not directly compared all available treatments, but individual study results provide useful context. The STEP trials demonstrated Wegovy's average 14.9% weight reduction over 68 weeks [1], whilst tirzepatide trials showed average reductions up to 22.5% at the highest dose [3]. Oral medications like orlistat work through fat absorption inhibition rather than appetite regulation, typically producing more modest weight loss of 3-5% [4].

Your choice of treatment depends on multiple factors: your BMI, comorbidities, tolerance for injections, lifestyle preferences, and budget. Our UK prescribers assess all these elements during your consultation, recommending the most suitable option for your individual circumstances. Many patients find Wegovy's once-weekly dosing schedule more convenient than daily injections, whilst others may prefer different mechanisms depending on their response and side effect profile.

Combining Wegovy with Lifestyle Changes

Clinical trials enrolled participants who also followed reduced-calorie diets and increased physical activity, and these lifestyle interventions remain essential components of successful weight management [1]. Wegovy is not a standalone solution but a tool that makes sustainable behaviour change more achievable by reducing appetite and food cravings. Your prescriber can provide guidance on evidence-based dietary approaches and activity goals that complement your medication.

How to Order Wegovy from Cured Pharmacy

Ordering Wegovy through Cured Pharmacy takes under 3 minutes. Start by completing our free online clinical assessment, which asks about your medical history, current medications, weight loss goals, and any relevant health conditions. This questionnaire is reviewed by a UK-registered prescriber who will determine whether Wegovy is safe and appropriate for you.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (registration number 9012511), where our team dispenses genuine UK-licensed Wegovy pens. We package your medication discreetly with no external branding and arrange delivery to your preferred address. Most orders are dispatched within 24-48 hours, and you'll receive tracking information so you can monitor your delivery every step of the way.

Ongoing support is included throughout your treatment. If you have questions about dosing, side effects, or your weight loss progress, our pharmacy team is available by phone on (+44) 116 4646009 or through our online messaging system. We also provide follow-up consultations when you need to reorder or adjust your treatment plan, ensuring continuity of care from a team that knows your medical history.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2014). Obesity: Identification, Assessment and Management (CG189). NICE Clinical Guideline. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and are influenced by diet, exercise, and adherence to treatment. Past clinical trial results do not guarantee individual outcomes.